News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Itonis Pharmaceuticals Joins The National Cannabis Industry Association To Advance Into The Medical Marijuana Products And Services Sector



4/1/2014 11:15:03 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LAGUNA HILLS, CA--(Marketwired - April 01, 2014) -

Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has joined the National Cannabis Industry Association (NCIA) as a member in a part of the Company's preparations to expand into the medical marijuana products and services sector. The Company is positioning itself for tremendous opportunities in this vibrant sector in unison with its recent app licensing agreement with MyECheck, Inc.

"NCIA is the only national trade association advancing the interests of the legitimate and responsible cannabis industry." (http://thecannabisindustry.org/)

NCIA's mission is to "promote the growth of a responsible and legitimate cannabis industry and work for a favorable social, economic and legal environment for that industry in the United States." (http://thecannabisindustry.org/about/mission-values/)

NCIA says that it "is the only national trade association advancing the interests of the legitimate and responsible cannabis industry. Our industry supports tens of thousands of jobs, tens of millions in tax revenue, and billions in economic activity in the United States. NCIA is leading the unified and coordinated campaign to ensure this emerging sector is treated fairly under federal law." (http://thecannabisindustry.org/)

About Itonis, Inc.
Itonis, Inc. was incorporated in the state of Nevada on July 5, 2005 under the name of Kenshou, Inc., which later changed to Itonis, Inc. on December 2, 2005. Please visit www.itonisholdings.com.

Safe Harbor:
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.


Contact:
Itonis, Inc.
Email Contact



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES